Canada can be a leader in delivering widespread, well-regulated psychedelic-assisted therapy for people with depression, anxiety, post-traumatic stress disorder and substance abuse, by investing in research, educating health care professionals and providing the necessary clinical infrastructure, Dr. Ross Marshall, chief scientific officer at The Newly Institute based in Calgary, says in an op-ed.
Organization: Cumming School of Medicine
The Short Report – June 1, 2022: IBM boosts research and innovation at Memorial U; formalizing a framework for AI and data science research, Ottawa supports a national energy modelling hub, and more.
IBM invests to strengthen research and innovation in Newfoundland and Labrador; a framework to deepen links between the NRC and Canada’s AI research and industry ecosystem, an energy hub to connect modellers and policymakers, and more.
UCalgary creates first Canadian investment fund for child health startups
The University of Calgary has created Canada’s first pre-seed and seed-stage investment fund for spinoffs focused on child health. The new “UCeed” investment program also includes one of the country’s few private equity funds managed by students.
The Short Report, March 25, 2020: Tech CEOs implore Ottawa to protect their industry, the NGEN supercluster commits $50M to scaling up production of supplies to fight COVID-19, and more
The Canadian Institutes of Health Research launched a new COVID-19 funding opportunity for operating grants called the “COVID-19 Clinical Epidemiology Research Rapid Response.” The application deadline is this Friday, March 27, and successful applicants will be notified of the decision on April 1. The competition description emphasizes the viruses “many unknown epidemiological parameters, particularly with respect…